Dr. Reddy's Announces Filing of Three NDAs With FDA
April 08, 2015 at 05:20 AM EDT
Dr. Reddy's Laboratories (NYSE: RDY) and its subsidiary, Promius Pharma, LLC today announced the filing of three 505(b)(2) New Drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.